NASDAQ:FTH | Profit Breakdown | Faeth Therapeutics, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$18.39M-$16.01M
2026-03-31-$170.63M-$170.24M
2025-12-31-$4.96M-$4.72M
2025-09-30-$4.85M-$4.57M
2025-06-30-$5.21M-$4.94M
2025-03-31-$7.27M-$6.86M
2024-12-31-$8.27M-$7.77M
2024-09-30-$7.82M-$7.25M
2024-06-30-$7.79M-$7.14M
2024-03-31-$8.73M-$7.99M
2023-12-31-$8.14M-$7.41M
2023-09-30-$7.74M-$7.12M
2023-06-30-$10.18M-$9.39M
2023-03-31-$11.01M-$10.18M
2022-12-31-$13.05M-$12.23M
2022-09-30-$13.94M-$13.42M
2022-06-30-$10.71M-$10.54M
2022-03-31-$12.49M-$12.41M
2021-12-31-$9.41M-$9.37M
2021-09-30-$10.32M-$9.69M
2021-06-30-$9.78M-$9.77M
2021-03-31-$7.97M-$7.97M
2020-12-31-$5.08M-$5.13M
2020-09-30-$5.36M-$5.37M
2020-06-30-$4.91M-$4.91M
2020-03-31-$4.1M-$4.69M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31-$22.29M-$21.09M-$21.09M
2024-12-31-$32.61M-$30.16M-$30.16M
2023-12-31-$37.06M-$34.1M
2022-12-31-$50.19M-$48.59M
2021-12-31-$37.48M-$36.79M
2020-12-31-$19.45M-$20.1M